Accesso libero

Effect of ultrasonic oscillation in combination with laser microsurgery on chronic periapical periodontitis

 e   
15 ago 2024
INFORMAZIONI SU QUESTO ARTICOLO

Cita
Scarica la copertina

General data (n, x̄± s)

Group n Age (year) Apical foramen diameter (mm) Gender Tooth position/n Etiology/n
M/F Maxillary anterior teeth/mandibular premolar/maxillary premolar Dental trauma/caries/central cusp deformity
Control 45 26.28±4.27 1.18±0.31 26/19 15/21/9 13/6/26
Treatment 45 25.91±4.30 1.20±0.33 24/21 12/23/10 14/8/23
t/χ2 0.410 0.296 0.180 0.477 0.506
P 0.683 0.768 0.671 0.788 0.776

O-PAI at different time points (x̄±s)

Group n Before treatment 4 weeks after treatment 8 weeks after treatment
Control 45 3.38±0.08 2.42±0.12 1.49±0.15
Ftime, Ptime 141.58, <0.001
ttime, Ptime (Bonferroni correction) Before vs. 4 weeks after treatment: 7.44, <0.001
Before vs. 8 weeks after treatment: 12.60, <0.001
4 vs. 8 weeks after treatment: 6.14, <0.001
Treatment 45 3.41±0.09 2.37±0.11 1.26±0.10
Ftime, Ptime 254.04, <0.001
ttime, Ptime (Bonferroni correction) Before vs. 4 weeks after treatment: 8.38, <0.001
Before vs. 8 weeks after treatment: 17.29, <0.001
4 vs. 8 weeks after treatment: 9.38, <0.001
tbetween groups 0.284 3.346 5.144
Pbetween groups 0.777 <0.001 <0.001

Serum biochemical indicators of bone formation (x̄± s)

Group n Ca (mmol/L) P (mmol/L) ALP (U/L)
Control 45 2.54±0.41 1.98±0.14 120.31±8.92
Treatment 45 3.20±0.53 2.35±0.23 150.94±10.83
t 6.607 9.218 14.645
P <0.001 <0.001 <0.001

Levels of inflammatory factors in GCF (x̄± s, µg/L)

Group n TNF-α IL-6 CRP
Before treatment After treatment Before treatment After treatment Before treatment After treatment
Control 45 7.65±0.94 2.95±0.62a 15.68±2.74 7.16±1.48a 2.68±0.48 1.38±0.41a
Treatment 45 7.72±1.03 2.46±0.43a 15.73±2.85 5.42±1.06a 2.71±0.53 1.05±0.32a
t 0.337 4.356 0.085 6.412 0.281 3.860
P 0.737 <0.001 0.933 <0.001 0.779 <0.001

Incidence of adverse reactions [n(%)]

Group n Local swelling Infection Nerve injury Incidence rate
Control 45 2 (4) 2 (4) 1 (2) 5 (10)
Treatment 45 1 (2) 0 (0) 1 (2) 2 (4)
χ2 1.394
P 0.238

Pain degree and MGV (x̄± s)

Group n VAS score (point) MGV
Before treatment 4 weeks after treatment 8 weeks after treatment Before treatment 4 weeks after treatment 8 weeks after treatment
Control 45 7.31±1.35 1.92±0.31 0.63±0.12 77.65±9.41 108.12±10.15 136.14±14.27
Ftime, Ptime 800.00, <0.001 1200.00, <0.001
ttime, Ptime (Bonferroni correction) Before vs. 4 weeks after treatment: 26.10, <0.001 Before vs. 4 weeks after treatment: 15.13, <0.001
Before vs. 8 weeks after treatment: 33.06, <0.001 Before vs. 8 weeks after treatment: 19.67, <0.001
4 vs. 8 weeks after treatment: 26.03, <0.001 4 vs. 8 weeks after treatment: 14.65, <0.001
Treatment 45 7.28±1.27 1.06±0.24 0.38±0.06 78.53±9.52 128.04±10.23 138.25±15.02
Ftime, Ptime 1200.00, <0.001 1500.00, <0.001
ttime, Ptime (Bonferroni correction) Before vs. 4 weeks after treatment: 32.28, <0.001 Before vs. 4 weeks after treatment: 24.55, <0.001
Before vs. 8 weeks after treatment: 36.41, <0.001 Before vs. 8 weeks after treatment: 22.69, <0.001
4 vs. 8 weeks after treatment: 18.44, <0.001 4 vs. 8 weeks after treatment: 5.45, <0.001
tbetween groups 0.109 14.715 12.500 0.441 9.273 0.683
Pbetween groups 0.914 <0.001 <0.001 0.660 <0.001 0.496

Treatment outcomes [n(%)]

Group n Cured Improved Ineffective Total effective rate
Control 45 25 (55) 12 (27) 8 (18) 37 (82)
Treatment 45 29 (65) 15 (33) 1 (2) 44 (98)
χ2 6.049
P 0.014
Lingua:
Inglese
Frequenza di pubblicazione:
1 volte all'anno
Argomenti della rivista:
Scienze biologiche, Biologia molecolare, Microbiologia e virologia, Medicina, Scienze medicali di base, Immunologia